Drug Trial Radar · NCT07073014
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
140
Planned (sponsor's estimate)
Start
Jun 20, 2025
Primary completion
Oct 2044
Study completion Oct 2044
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jul 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and efficacy of daily doses of vosoritide in participants with HCH
Conditions
- Hypochondroplasia
Interventions
VosoritideDrug
Open-label administration of vosoritide using weight-band dosing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the long-term efficacy of vosoritide treatment until final adult height (FAH)Time frame: Annually from enrollment through Final Adult Height, defined as 16 years of age for females and 18 years of age for males
Locations
30 sites in 9 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital - Thomas Campus
Phoenix, Arizona
Benioff Children's Hospital - Oakland
Oakland, California
Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children)
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
The Johns Hopkins University School of Medicine
Baltimore, Maryland
University of Minnesota Masonic Children's Hospital
Minneapolis, Minnesota
University of Missouri
Columbia, Missouri
Cook Children's Endocrinology
Fort Worth, Texas
Medical College of Wisconsin
Milwaukee, Wisconsin
Murdoch Children's Research Institute of The Royal Children's Hospital
Parkville, Victoria, Australia
University of Alberta Stollery Children's Hospital
Edmonton, Alberta, Canada
SickKids - The Hospital for Sick Children
Toronto, Ontario, Canada
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
Hospices Civils de Lyon - Hopital Femme Mere Enfant
Lyon, France
Hopital de la Timone
Marseille, France
Hopital Necker-Enfants Malade
Paris, France
CHU de Toulouse
Toulouse, France
Uniklinik Koln
Cologne, Germany
Univeristatskinderklinik Magdeburg
Magdeburg, Germany
Universitätsklinikum des Saarlandes
Homburg, Saarland, Germany
Instituto Giannina Gaslini
Genoa, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Ospedale Pediatrico Bambino Gesu
Rome, Italy
Osaka University Hosptial
Osaka, Japan
Tokushima University Hospital
Tokushima, Japan
Institute of Science Tokyo Hospital
Tokyo, Japan
Tottori University Hospital
Tottori, Japan
Hospital MiKS - Unidad de Cirugía Artroscópica
Vitoria-Gasteiz, Spain
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.